Purpose <p>The impact of preoperative MRI on breast cancer recurrence and long-term outcomes remains undefined. Therefore, this study aims at determining the influence of preoperative MRI on in-breast tumor recurrence rates in cases of surgical treatment for breast cancer.</p> Methods <p>A systematic review and meta-analysis were performed. Literature searches of PubMed, Scopus, and Google Scholar were conducted for studies up to February 2024. Two authors assessed the quality of the eligible studies and extracted their data.</p> Results <p>The meta-analysis included 14 studies (2 RCTs, 12 cohort studies) with 12,889 patients with 5,451 undergoing preoperative MRI. Pooled hazard ratio for in-breast tumor recurrence was 0.95, using fixed effects and 0.94 using random effects models with 95% confidence intervals of 0.80–1.14 and 0.77–1.14, respectively. A trend towards lower recurrence rates in the MRI group was seen, but the reduction was not statistically significant.</p> Conclusion <p>This meta-analysis found no significant reduction in in-breast tumor recurrence rates associated with preoperative MRI use in breast cancer patients, consistent with previous findings.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

The effect of pre-operative MRI on the in-breast tumor recurrence rate of patients with breast cancer: a meta-analysis

  • Mahdieh Khoshzaban Banisi,
  • Hani Ghadri,
  • Behnaz Soltani,
  • Amirali Farshid,
  • Bahar Behnam,
  • Amir Abbas Rhouholamini,
  • Amirhossein Mohammadi,
  • Seyedeh Fatemeh Hamzavi,
  • Ashkan Azizi,
  • Niloofar Deravi,
  • Masoud Noroozi,
  • Amin Magsudy,
  • Sina Seyedipour,
  • Shima Behzad,
  • Yaser Khakpour

摘要

Purpose

The impact of preoperative MRI on breast cancer recurrence and long-term outcomes remains undefined. Therefore, this study aims at determining the influence of preoperative MRI on in-breast tumor recurrence rates in cases of surgical treatment for breast cancer.

Methods

A systematic review and meta-analysis were performed. Literature searches of PubMed, Scopus, and Google Scholar were conducted for studies up to February 2024. Two authors assessed the quality of the eligible studies and extracted their data.

Results

The meta-analysis included 14 studies (2 RCTs, 12 cohort studies) with 12,889 patients with 5,451 undergoing preoperative MRI. Pooled hazard ratio for in-breast tumor recurrence was 0.95, using fixed effects and 0.94 using random effects models with 95% confidence intervals of 0.80–1.14 and 0.77–1.14, respectively. A trend towards lower recurrence rates in the MRI group was seen, but the reduction was not statistically significant.

Conclusion

This meta-analysis found no significant reduction in in-breast tumor recurrence rates associated with preoperative MRI use in breast cancer patients, consistent with previous findings.